Meihao Medical Group Co., Ltd (HKG:1947)
Hong Kong · Delayed Price · Currency is HKD 0.5400
-0.0100 (-1.82%)
Sep 1, 2026, 2:18 PM HKT
Meihao Medical Group Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 324 | 222 | 222 | 261 | 297 | - | |
Market Cap Growth | 27.06% | 0% | -14.92% | -12.12% | - | - |
Enterprise Value | 246 | 177 | 118 | 138 | 291 | - |
Last Close Price | 0.54 | 0.37 | 0.37 | 0.42 | 0.48 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 9.23 | - |
PS Ratio | 2.43 | 1.96 | 2.79 | 3.22 | 2.06 | - |
PB Ratio | 2.89 | 1.86 | 1.73 | 1.43 | 1.48 | - |
P/TBV Ratio | 3.34 | 2.12 | 1.94 | 1.44 | 1.49 | - |
P/FCF Ratio | - | 32.89 | - | 4645.34 | 10.87 | - |
P/OCF Ratio | - | 12.96 | - | 42.06 | 8.26 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.84 | 1.57 | 1.49 | 1.70 | 2.02 | - |
EV/EBITDA Ratio | - | - | - | - | 5.29 | - |
EV/EBIT Ratio | - | - | - | - | 6.05 | - |
EV/FCF Ratio | - | 26.27 | - | 2451.28 | 10.66 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.13 | 0.24 | 0.28 | 0.20 | 0.21 | 0.88 |
Debt / EBITDA Ratio | - | - | - | 10.95 | 0.66 | 0.80 |
Debt / FCF Ratio | - | 4.28 | - | 661.20 | 1.52 | 1.56 |
Net Debt / Equity Ratio | -0.71 | -0.60 | -0.37 | -0.65 | -0.30 | 0.06 |
Net Debt / EBITDA Ratio | 6.81 | 5.28 | 1.71 | 29.59 | -1.09 | 0.07 |
Net Debt / FCF Ratio | - | -10.60 | 2.28 | -2122.55 | -2.19 | 0.11 |
Asset Turnover | 0.63 | 0.55 | 0.35 | 0.30 | 0.66 | 0.91 |
Inventory Turnover | 23.75 | 23.24 | 19.47 | 16.33 | 20.23 | 19.45 |
Quick Ratio | 1.45 | 2.06 | 2.10 | 3.87 | 4.17 | 0.96 |
Current Ratio | 1.75 | 2.15 | 2.45 | 4.01 | 4.28 | 1.16 |
Return on Equity (ROE) | -13.22% | -12.44% | -22.82% | -7.93% | 25.03% | 93.39% |
Return on Assets (ROA) | -6.83% | -6.96% | -9.71% | -2.82% | 13.76% | 24.03% |
Return on Invested Capital (ROIC) | -71.29% | -34.97% | -49.48% | -12.02% | 33.86% | 97.22% |
Return on Capital Employed (ROCE) | -16.30% | -15.40% | -21.90% | -5.60% | 20.10% | 51.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -4.89% | -7.19% | -15.54% | -5.74% | 10.83% | - |
FCF Yield | - | 3.04% | -9.46% | 0.02% | 9.20% | - |
Dividend Yield | - | - | - | 2.36% | - | - |
Buyback Yield / Dilution | -5.76% | 0.03% | 3.01% | -31.18% | -1.64% | - |
Total Shareholder Return | -5.76% | 0.03% | 3.01% | -28.82% | -1.64% | - |